KORU Medical Systems, Inc. (KRMD)
NASDAQ: KRMD · Real-Time Price · USD
4.230
-0.020 (-0.47%)
At close: Oct 24, 2025, 4:00 PM EDT
4.240
+0.010 (0.24%)
After-hours: Oct 24, 2025, 4:10 PM EDT
KORU Medical Systems Market Cap
KORU Medical Systems has a market cap or net worth of $196.04 million as of October 24, 2025. Its market cap has increased by 66.41% in one year.
Market Cap
196.04M
Enterprise Value
191.45M
1-Year Change
66.41%
Ranking
Category
Stock Price
$4.23
Market Cap Chart
Since December 1, 1998, KORU Medical Systems's market cap has increased from $1.00M to $196.04M, an increase of 19,503.62%. That is a compound annual growth rate of 21.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 196.00M | 11.05% |
| Dec 31, 2024 | 176.50M | 57.45% |
| Dec 29, 2023 | 112.10M | -30.63% |
| Dec 30, 2022 | 161.60M | 20.87% |
| Dec 31, 2021 | 133.70M | -49.45% |
| Dec 31, 2020 | 264.50M | 2.56% |
| Dec 31, 2019 | 257.90M | 322.09% |
| Dec 31, 2018 | 61.10M | 28.90% |
| Dec 29, 2017 | 47.40M | 150.79% |
| Dec 30, 2016 | 18.90M | -9.57% |
| Dec 31, 2015 | 20.90M | 16.76% |
| Dec 31, 2014 | 17.90M | 123.75% |
| Dec 31, 2013 | 8.00M | -4.76% |
| Dec 31, 2012 | 8.40M | -16.00% |
| Dec 30, 2011 | 10.00M | 104.08% |
| Dec 31, 2010 | 4.90M | -27.94% |
| Dec 31, 2009 | 6.80M | 7.94% |
| Dec 31, 2008 | 6.30M | 1.61% |
| Dec 31, 2007 | 6.20M | 313.33% |
| Dec 29, 2006 | 1.50M | -50.00% |
| Dec 30, 2005 | 3.00M | 20.00% |
| Dec 31, 2004 | 2.50M | 177.78% |
| Dec 31, 2003 | 900.00K | 28.57% |
| Dec 31, 2002 | 700.00K | -70.83% |
| Dec 31, 2001 | 2.40M | -36.84% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 729.35B |
| Johnson & Johnson | 464.66B |
| AbbVie | 403.98B |
| UnitedHealth Group | 327.39B |
| AstraZeneca | 259.95B |
| Novartis AG | 255.24B |
| Novo Nordisk | 237.27B |
| Abbott Laboratories | 222.69B |